This Late Billionaire's Most Interesting Holdinghttp://www.fool.com/investing/general/2014/01/12/this-late-billionaires-most-interesting-holding.aspx Bob Chandler
January 12, 2014
Renowned takeover artist and financier Harold Simmons passed away recently. Thanks to a savvy investing instinct, he was able to amass a multi-billion dollar empire during his life. One of his holdings included Kronos Worldwide (NYSE: KRO), a titanium dioxide, or TiO2, producer. Though the TiO2 industry has had its troubles, there are signs things may be turning around. If they do, Kronos, with competitors DuPont (NYSE: DD) and Huntsman Corp. (NYSE: HUN), could see its shares advance. Here's a quick look at a fascinating investor and one of his most interesting holdings.
Who was Harold Simmons?
Mr. Simmons, estimated to be worth $8 billion in 2013, has owned or tried to acquire many businesses over the years, but one of his most notable raids was on defense contractor Lockheed Corporation in 1989. After Pentagon budget cuts depressed military contractor shares, Simmons gradually acquired almost 20% of the stock. Eyeing a $1.4 billion over-funded pension, many believed, the corporate raider withdrew only after Lockheed put up a stubborn poison-pill defense and won a hard fought proxy contest.
An astute investor, he described his stock picking style as "opportunistic" rather than proceeding by grand design. He also noted, "I look for value-financial and otherwise-that I feel has been overlooked by the market." Simmons also prudently avoided situations where he did not perceive an edge. "I try to stay away from regulated industries, and I try to stay away from high tech because I don't understand it," the financier stressed.
An interesting Simmons holding in a depressed industry
Kronos was not the only company to suffer. Chemicals industry giant DuPont, the world's largest TiO2 producer, found its titanium dioxide business to be depressing overall results. The company's TiO2 subsidiary, held in the performance chemicals division, was a notable laggard. DuPont reported a 5% year-over-year rise in operating earnings per share in its latest quarter with all company divisions producing sales and earnings improvements except performance chemicals. So, the subsequent plan to spin off the $7 billion segment wasn't too surprising. The split should help DuPont focus its substantial scientific expertise on secular growth markets like food, energy, and advanced materials, with shareholders ultimately benefiting.
The divestiture might help the TiO2 business as well. A leading player, DuPont Titanium Technologies, will have an incentive to help rationalize the industry. The firm's October product-pricing increase may be a sign of its intentions. Sustained higher selling prices are just what the industry needs to emerge from its slump. Kronos has also hinted that improved revenues may be on the horizon. It reported TiO2 selling prices decreased 18% year over year in the most recent quarter. A dismal figure, it was still a noticeable improvement over the 21% decline averaged over the first nine months of the year.
A stronger TiO2 industry on the horizon?